Selected research from leading health care experts whose findings have a direct bearing on public policies effecting medical progress. Research is chosen based on its quality and relevance by the Medical Progress Today editorial staff.

Selected Research

Examining the Link Between Price Regulation, Reimportation, and Pharmaceutical R&D Investment
John Vernon, AEI-Brookings Joint Center for Regulatory Studies, 4-1-04

This paper examines the link between prices and investment, and considers re-importation as another mechanism to control pharmaceutical prices. Vernon finds that if the U.S. imposed price controls on drugs it would lead to a 23% to 33% decline in industry R&D. Vernon's findings suggest that drug importation, far from being harmless, would slow the advancement of the next generation of critical medicines.

Project FDA.
home   spotlight   commentary   research   events   news   about   contact   links   archives
Copyright Manhattan Institute for Policy Research
52 Vanderbilt Avenue
New York, NY 10017
(212) 599-7000